Vandetanib

Siamenoside I is one of the mogrosides that has several kinds of bioactivities.In vitroSiamenoside I is the sweetest mogroside that has several kinds of bioactivities, and it is also a constituent of Siraitiae Fructus, a fruit and herb in China.

Siamenoside I is one of the mogrosides that has several kinds of bioactivities.In vitroSiamenoside I is the sweetest mogroside that has several kinds of bioactivities, and it is also a constituent of Siraitiae Fructus, a fruit and herb in China.

Sunitinib-d 10 is a deuterium labeled Sunitinib. Sunitinib is a multi-targeted receptor tyrosine kinase inhibitor with IC50s of 80 nM and 2 nM for VEGFR2 and PDGFRβ , respectively. Sunitinib, an ATP-competitive inhibitor, effectively inhibits

Sunitinib-d 10 is a deuterium labeled Sunitinib. Sunitinib is a multi-targeted receptor tyrosine kinase inhibitor with IC50s of 80 nM and 2 nM for VEGFR2 and PDGFRβ , respectively. Sunitinib, an ATP-competitive inhibitor, effectively inhibits

A broad spectrum, orally available kinase inhibitor that targets primarily tyrosine kinases, including VEGFR and EGFR, with IC₅₀ values in the nanomolar range also potently blocks non-receptor tyrosine kinases, including ABL, RET, and

A broad spectrum, orally available kinase inhibitor that targets primarily tyrosine kinases, including VEGFR and EGFR, with IC₅₀ values in the nanomolar range also potently blocks non-receptor tyrosine kinases, including ABL, RET, and

Vandortuzumab (anti-STEAP1) is a recombinant monoclonal antibody that specifically targets STEAP1. It has potential for the treatment of prostate cancer.Purity&gt:95% (SDS-PAGE&amp:SEC)Endotoxin Level&lt: 1.0EU/mg.

Vandortuzumab (anti-STEAP1) is a recombinant monoclonal antibody that specifically targets STEAP1. It has potential for the treatment of prostate cancer.Purity&gt:95% (SDS-PAGE&amp:SEC)Endotoxin Level&lt: 1.0EU/mg.

Vandortuzumab (anti-STEAP1) is a recombinant monoclonal antibody that specifically targets STEAP1. It has potential for the treatment of prostate cancer.Purity&gt:95% (SDS-PAGE&amp:SEC)Endotoxin Level&lt: 1.0EU/mg.

Vandortuzumab (anti-STEAP1) is a recombinant monoclonal antibody that specifically targets STEAP1. It has potential for the treatment of prostate cancer.Purity&gt:95% (SDS-PAGE&amp:SEC)Endotoxin Level&lt: 1.0EU/mg.

VANILLYLIDENEMALONONITRILE-